2020-08-12T10:35:06-05:00 2019-09-30 ERNST & YOUNG US LLP 200 CLARENDON STREET BOSTON MA 021165072 990 2018-10-01 043320640 DANA-FARBERPARTNERS CANCER CARE INC % MELISSA CHAMMAS DANA 6176323000 450 Brookline Ave BP418 Boston MA 02215 SALLY MASON BOEMER TREASURER 6176323000 2020-08-05 true BARBARA E HUNT P00916443 6172662000 2020-08-04 76.19.246.55 02007720202255000000 2020-08-12 P 120CEB144A09B0F247B212AAF84468814E75FA3B 79DE44365921E24D8255237D08E513902394227B 2018 2020-09-22 18:59:49Z Laurie Glimcher MD 450 Brookline Ave Boston MA 02215 87429489 false X www.cancercare.harvard.edu X 1996 MA COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL AND BRIGHAM AND WOMEN'S HOSPITAL 7 6 0 0 0 0 0 0 82862296 87360268 67883 69221 0 0 82930179 87429489 0 0 0 0 560501 621921 0 0 0 82387684 86902137 82948185 87524058 -18006 -94569 26437666 29516581 18940473 21893747 7497193 7622834 COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL AND BRIGHAM AND WOMEN'S HOSPITAL false false 86658458 0 86658458 Clinical trial studies and research related to investigating new medications and methods of treatment of cancer, with hope of finding a cure 136768 0 351833 Development of clinical guidelines, protocols and standards of care for the treatment of cancer, as well as establishing priorities for research 349977 0 349977 Educational programs and materials for consumers and healthcare professionals pertaining to developing cancer awareness, knowledge of available treatment methods and updates of current research 0 0 0 87145203 true false false false false false false false false false false false false false true false true false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 0 0 0 false false false false false false false false false false false false X 7 6 true false false false true true true true true false false true true true true true true true false false MA X MELISSA CHAMMAS 6176323000 C/O DFCI 450 BROOKLINE AVE BP418 Boston MA 02215 Edward Lawrence Chairman & Trustee 1.0 0.0 X X 0 0 0 Joshua Bekenstein Trustee 1.0 0.0 X 0 0 0 Charles Gifford Trustee 1.0 0.0 X 0 0 0 Richard Lubin Trustee 1.0 0.0 X 0 0 0 Marshall Moriarty Trustee 1.0 0.0 X 0 0 0 Vincent O'Reilly Trustee 1.0 0.0 X 0 0 0 Laurie H Glimcher MD President & Trustee 8.0 42.0 X X 35655 1440948 290345 Sally Mason Boemer Treasurer 1.0 49.0 X 0 1055393 65358 Dorothy Puhy Chief Administrative Officer 1.0 49.0 X 0 848026 45426 Richard Boskey ESQ Clerk 1.0 49.0 X 0 593401 68586 Edward J Benz Jr MD Former Officer 0.0 0.0 X 0 1526785 56454 35655 5464553 526169 0 true true false Dana-Farber Cancer Institute Inc 450 Brookline Ave BP418 BOSTON MA 02215 Research Services 51817131 Massachusetts General Hospital 55 Fruit St BOSTON MA 02114 Research Services 27928003 Beth Israel Deaconess Medical Cente 110 Francis Street BOSTON MA 02115 Research Services 3346929 Brigham and Women's Hospital 75 Francis St BOSTON MA 02115 Research Services 1747820 SARAH CANNON RESEARCH INSTITUTE LL 250 25TH AVE N NASHVILLE TN 37203 Research Services 175377 8 0 CLINICAL TRIALS/RESEARCH 621500 86658458 86658458 CONTRACT SERVICES 621400 685143 685143 AFFILIATION FEES 611600 16667 16667 87360268 69221 69221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 87429489 87360268 69221 0 0 0 0 35655 35655 0 450221 323152 127069 0 136045 90482 45563 0 0 0 27000 27000 0 0 0 86726158 86726158 0 0 143568 143568 0 0 0 0 4000 4000 0 0 0 0 MISCELLANEOUS 1411 1411 87524058 87145203 378855 0 19634586 22188025 6404039 6693470 0 0 399041 635086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 26437666 29516581 49289 27000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18891184 21866747 18940473 21893747 X 7497193 7622834 0 0 0 0 7497193 7622834 26437666 29516581 -94569 220210 X false true X true false X X 3 DANA-FARBER CANCER INSTITUTE INC 042263040 3 true 0 0 THE GENERAL HOSPITAL CORPORATION 042697983 3 true 0 0 BRIGHAM & WOMEN'S HOSPITAL 042312909 3 true 0 0 3 true false false false false false false false false false false false false false false false true Part I, Line 12 Dana-Farber/Partners Cancer Care, Inc. ("DF/PCC Inc.") supports only Dana-Farber Cancer Institute, Inc., The General Hospital Corporation, and Brigham & Women's Hospital. DF/PCC Inc. does not provide direct monetary support to these entities. It is our understanding that monetary support is not required but support can be in the form of services performed. In this situation, DF/PCC Inc. provides support for educational programs, clinical trial studies, and research to the supported organizations. Part IV, Section B Pursuant to DF/PCC Inc.'s Articles of Organization, it "is organized and shall be operated exclusively for the benefit of The Brigham and Women's Hospital, Inc. ('BWH'), Dana-Farber Cancer Institute, Inc. ('DFCI'), and the General Hospital Corporation ('MGH')". BWH, DFCI and MGH are publicly supported organizations within the meaning of 26 USC 509(a). Under DF/PCC Inc.'s By-laws, DFCI and Partners Healthcare Systems, Inc., as the two corporate members of DF/PCC Inc., have the power to appoint an equal proportion of the members of DF/PCC, Inc.'s Board of Trustees. DF/PCC Inc. benefits the BWH, DFCI and MGH by performing services in connection with education programs, clinical trials, and other research programs for the hospitals. In this way, DFCI's and Partners' purposes of providing excellent medical care and engaging in critical cancer research are served by the support that DF/PCC Inc. provides to the hospitals. Under 26 CFR 1.509(a)-4(g)(ii), DF/PCC, Inc. is considered to be "controlled by" DFCI and Partners within the meaning of 26 USC 509(a)(3)(B), even though DF/PCC Inc. is "operated for the benefit of" the hospitals within the meaning of 509(a)(3)(A). 0 RESEARCH ADVANCES 21866747 21866747 87429489 87429489 87429489 87524058 87524058 87524058 false true false false false false false false false Sally Mason Boemer Treasurer 0 769032 0 214000 0 72361 0 30250 0 35108 0 1120751 0 0 Edward J Benz Jr MD Former Officer 0 944229 0 0 0 582556 0 38955 0 17499 0 1583239 0 0 Laurie H Glimcher MD President & Trustee 35655 1140233 0 173019 0 127696 0 277441 0 12904 35655 1731293 0 0 Dorothy Puhy Chief Administrative Officer 0 702139 0 77564 0 68323 0 38955 0 6471 0 893452 0 0 Richard Boskey ESQ Clerk 0 513146 0 38232 0 42023 0 38955 0 29631 0 661987 0 0 Schedule J The deferred comp awards/other benefits figure may include awards of deferred compensation, the value of other employee taxable benefits in which the employee participates, such as life insurances, deferred compensation plans, tuition benefit plans, housing allowances, and the value of non-taxable employee benefit plans such as pension, group health, life, and disability which the employer provides to employees on a non-discriminatory basis as required by the IRS. None of the officers or employees receive expense accounts or allowances which constitute taxable compensation. The Corporation has an "accountable plan" which pays for or reimburses expenses only if they are "ordinary, necessary, and reasonable" expenses "incurred for a bona fide business purpose." The Corporation carries liability insurance that covers its Trustees and Officers. This insurance coverage provides an incidental benefit to the covered individuals. Schedule J, Part I line 3 PROCESS FOR DETERMINING COMPENSATION OF PRESIDENT: EACH YEAR THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF DFCI REVIEWS THE DFCI PRESIDENT'S (DF/PCC'S PRESIDENT AND CHIEF EXECUTIVE OFFICER) PERFORMANCE AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO DFCI'S EXECUTIVE COMMITTEE, WHICH THEN APPROVES SUCH COMPENSATION. A PORTION OF THAT COMPENSATION IS ALLOCATED TO DF/PCC, BASED ON A REASONABLE DETERMINATION OF THE SERVICES PROVIDED TO DF/PCC. Schedule J, Part I, Line 4B The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Benz, Edward J. JR., MD 83,992 Boskey, Richard S., ESQ 30,852 GLIMCHER, LAURIE, MD 113,218 Puhy, Dorothy 53,846 Part VI, Line 2 DR. LAURIE GLIMCHER, DOROTHY PUHY, AND RICHARD BOSKEY WERE EACH EMPLOYED BY DFCI, OF WHICH JOSHUA BEKENSTEIN, RICHARD LUBIN, AND VINCENT O'REILLY WERE EACH TRUSTEES. SALLY MASON BOEMER WAS EMPLOYED BY PARTNERS HEALTHCARE OR ONE OF ITS AFFILIATED HOSPITALS, OF WHICH EDWARD LAWRENCE, CHARLES GIFFORD, AND MARSHALL MORIARTY WERE EACH TRUSTEES. PART VI, LINE 6 DFCI AND PARTNERS HEALTHCARE SYSTEMS, INC. ARE THE MEMBERS OF DFPCC, INC. PART VI, LINES 7A & 7B THE MEMBERS HAVE THE AUTHORITY TO ELECT OR APPOINT THE GOVERNING BODY OF DFPCC. CERTAIN GOVERNANCE DECISIONS RELATING TO SIGNIFICANT TRANSACTIONS, AMENDMENTS TO THE GOVERNING DOCUMENTS OF THE CORPORATION AND THE DISSOLUTION OF THE CORPORATION ARE RESERVED TO THE MEMBERS. PART VI, LINE 11 PROCESS USED TO REVIEW THE FOM 990 THE FORM 990 IS PREPARED BY THE TAX DEPARTMENT OF DFCI AND INDEPENDENTLY REVIEWED BY ERNST & YOUNG LLP FOR TECHNICAL TAX ISSUES. AFTER THE TAX DEPARTMENT AND ERNST & YOUNG FINALIZE THE RETURNS, THE CHIEF FINANCIAL OFFICER OF DFCI MEETS WITH THE TAX DEPARTMENT TO REVIEW THE TAX RETURN. IF ANY CHANGES NEED TO BE MADE, THE TAX DEPARTMENT WILL MAKE THE CHANGES IN ACCORDANCE WITH THE CFO. AN ELECTRONIC MESSAGE IS SENT TO ALL BOARD MEMBERS WITH A SECURED LINK TO THE TAX RETURN. THE BOARD HAS THE OPPORTUNITY TO REVIEW THE RETURN AND IF ANY ISSUES ARISE, THEY CAN BRING THEM TO THE APPROPRIATE EXECUTIVE MANAGEMENT INDIVIDUALS. THE RETURN IS ONLY FILED AFTER EACH OF THE STEPS IN THE REVIEW PROCESS IS COMPLETE. PART VI, LINE 12C DFPCC HAS A WRITTEN CONFLICT OF INTEREST POLICY THAT IS CONSISTENT WITH THE IRS SAMPLE CONFLICT OF INTEREST POLICY. PER THE DFPCC CONFLICT OF INTEREST POLICY, THE TRUSTEES AND OFFICERS OF DFPCC ARE REQUIRED ANNUALLY TO DISCLOSE POTENTIAL CONFLICTS. PER THE DFPCC CONFLICT OF INTEREST POLICY, IN ORDER TO AVOID A CONFLICT OF INTEREST OR AN APPEARANCE OF A CONFLICT OF INTEREST A TRUSTEE SHOULD NOT PARTICIPATE IN A VOTE ON A TRANSACTION IN WHICH THE TRUSTEE OR FAMILY MEMBER HAS A FINANCIAL INTEREST AND SHOULD DISCLOSE ANY POTENTIAL CONFLICT BEFORE DFPCC ACTS ON THE TRANSACTION. IF A DISCLOSURE WAS MADE, THE BOARD OF TRUSTEES WOULD INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION AND DETERMINE WHETHER A MORE ADVANTAGEOUS TRANSACTION THAT WOULD NOT GIVE RISE TO A CONFLICT WOULD BE REASONABLY ATTAINABLE. IF SUCH A TRANSACTION IS NOT ATTAINABLE, A TRANSACTION WITH A TRUSTEE, A MEMBER OF HIS OR HER FAMILY, OR AN ENTITY WITH WHICH ONE OR MORE OF THEM HAS A MATERIAL INTEREST, MAY BE APPROVED BY THE MAJORITY VOTE OF THE DISINTERESTED TRUSTEES. PART VI, LINE 15A PROCESS FOR DETERMINING COMPENSATION OF PRESIDENT: EACH YEAR THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF DFCI REVIEWS THE DFCI PRESIDENT'S (DF/PCC'S PRESIDENT AND CHIEF EXECUTIVE OFFICER) PERFORMANCE AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO DFCI'S EXECUTIVE COMMITTEE, WHICH THEN APPROVES SUCH COMPENSATION. A PORTION OF THAT COMPENSATION IS ALLOCATED TO DF/PCC, BASED ON A REASONABLE DETERMINATION OF THE SERVICES PROVIDED TO DF/PCC. PART VI, LINE 19 AVAILABILITY OF GOVERNING DOCS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS: WE CURRENTLY PROVIDE THE GOVERNING DOCUMENTS UPON REQUEST. THE ARTICLES OF ORGANIZATION ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY - DF/PCC INC'S CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS - DF/PCC PROVIDES THE AUDITED FINANCIAL STATEMENTS UPON REQUEST. FORM 990 PART IX LINE 11G DESCRIPTION:INST SUPPORT TOTAL FEES:86658458 FORM 990 PART IX LINE 11G DESCRIPTION:MEDICAL FEES TOTAL FEES:67700 Dana-Farber Cancer Institute Inc 450 Brookline Ave Boston MA 02215 042603040 Cancer Care MA 501(c)(3) 7 NA false The General Hospital Corporation 55 Fruit Street Boston MA 02114 042697983 Hospital MA 501(c)(3) 3 NA false The Brigham & Women's Hospital 75 Francis Street Boston MA 02115 042312909 Hospital MA 501(c)(3) 3 NA false false false false false false false false false false false false true false true false false false true Dana-Farber Cancer Institute Inc o 35655 cash The Brigham and Women's Hospital s 171285 cash Dana-Farber Cancer Institute Inc s 260354 cash The General Hospital Corporation s 253503 Cash Dana-Farber Cancer Institute Inc m 53226263 Cost The Brigham and Women's Hospital m 2821016 Cost The General Hospital Corporation m 25122409 Cost